Dow Inc. filings document the company's public reporting as a Delaware materials science issuer with common stock listed on the New York Stock Exchange. Its 8-K filings furnish quarterly results and financial condition updates, including segment sales, pricing, volume, operating items and equity-method matters tied to businesses such as Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Dow's regulatory record also includes proxy materials for director elections, executive compensation, stock incentive plan approvals, auditor ratification and stockholder advisory votes. Other filings address board and officer changes, exit and disposal cost accruals, exhibits incorporated into Form 10-K reporting, and the capital structure of Dow Inc. common stock and The Dow Chemical Company exchange-listed notes.
Dow Inc. officer Philo B. Lange reported a proposed sale of 3,976 shares of common stock, with an aggregate market value of $135,319.98. The approximate sale date is November 2, 2026. The securities-to-be-sold table identifies restricted-stock vesting and performance stock units as compensation-related acquisitions from the issuer.
Dow Inc. Chief Financial Officer Jeffrey L. Tate had 25,564 shares of common stock withheld by the issuer on October 26, 2026, to satisfy tax withholding upon settlement of previously reported awards. The reported price was $33.99 per share. He held 93,197 shares directly after the transaction; that total includes previously reported restricted stock units.
Dow Inc. lists equity positions for Charles Ross Zimmer Jr., President, Perf Mat & Coatings, as of October 15, 2026: 5,671 directly held common shares, 1,035 shares held by his spouse and 5,517 through a 401(k) plan. He also holds four direct non-qualified stock options covering 2,647, 3,771, 4,990 and 11,002 shares, with exercise prices of $59.08, $55.17, $38.34 and $32.65, respectively. The options have different vesting schedules and expire between February 9, 2033, and February 12, 2036.
Dow Inc. reported third-quarter 2026 net sales of $11.267 billion, versus $9.973 billion a year earlier, and net income available to Dow Inc. common stockholders of $458 million, versus $62 million. Diluted earnings were $0.62 per share, compared with $0.08. For the first nine months of 2026, net sales were $33.153 billion versus $30.508 billion, and income available to common stockholders was $646 million versus a $1.080 billion loss. Cash provided by operating activities was $4.293 billion, compared with $748 million in the prior-year period.
Dow's Transform to Outperform program includes a workforce reduction of approximately 4,500 roles, expected to be substantially complete by the end of 2027. At September 30, 2026, Dow had recorded $481 million of inception-to-date severance and related benefit charges and made $214 million in related payments. Environmental remediation and restoration obligations accrued were $991 million at September 30, 2026. Dow said ultimate costs for these accrued matters could range up to approximately 2.5 times the estimate, and costs above accruals could materially affect results, financial condition and cash flows.
Dow Inc. reported third-quarter 2026 net sales of $11.267 billion, up 13% year over year, as local price rose 14%; volume declined 1%. GAAP net income was $525 million, compared with $124 million a year earlier. Operating EBIT, a non-GAAP measure, was $887 million versus $180 million; diluted GAAP EPS was $0.62 versus $0.08, and operating EPS was $0.71 versus a loss of $0.19.
Packaging & Specialty Plastics sales rose 18%, while Industrial Intermediates & Infrastructure and Performance Materials & Coatings sales each rose 8%. Industrial Intermediates & Infrastructure volume fell 7%, with lower volumes in Polyurethanes & Construction Chemicals. Cash provided by operating activities from continuing operations was $1.839 billion, up $709 million year over year; free cash flow was $1.133 billion versus $566 million. Dow paid $253 million in dividends during the quarter. Management said its self-help actions are on track to deliver more than $1 billion of EBITDA uplift in both 2026 and 2027.
DOW INC. (DOW) received a Rule 144 notice indicating that company officer Marco ten Bruggencate plans to sell up to 16,184 shares of DOW common stock through Fidelity Brokerage Services LLC. The shares have an indicated aggregate market value of $482,150.55 and are expected to be sold on or after September 10, 2026 on the NYSE.
The 16,184 shares were acquired between October 4, 2024 and February 26, 2026 through a mix of Employee Stock Purchase Plan purchases and restricted stock vesting events from the issuer.
DOW INC. executive de Mattos Cunha Neto Nestor, President, Ind Interm & Infras, reported his initial ownership on Form 3. He holds 11,042.501 shares of common stock directly, including restricted stock units scheduled for delivery in 2027, 2028 and 2029 subject to continued employment.
He also holds several direct non-qualified stock options over common stock, with exercise prices between $32.65 and $72.77 per share and expirations from 2028 to 2036. Some options are fully exercisable, while others vest in tranches through 2029, with certain option shares designated to satisfy withholding taxes.
State Street Corporation filed a Schedule 13G reporting beneficial ownership of common stock of Dow Inc.. State Street reports beneficial ownership of 37,921,179 shares of Dow Inc. common stock, representing 5.3% of the class.
State Street has no sole voting or dispositive power over Dow shares. It reports shared voting power over 25,164,894 shares and shared dispositive power over 37,869,410 shares through affiliated investment adviser subsidiaries, including various State Street Global Advisors entities.
Dow Inc. reported a sharp turnaround in the second quarter of 2026. Net sales were $12,092 million, up 20% year-over-year on 20% higher local prices and a 1% currency tailwind, partially offset by a 1% volume decline. GAAP net income was $802 million versus a prior-year loss of $801 million, with GAAP EPS of $0.99. Non-GAAP Operating EBIT rose to $1,648 million from $(21) million and operating EPS to $1.44 from $(0.42), excluding significant items largely tied to restructuring and Transform to Outperform.
Packaging & Specialty Plastics led results with net sales of $6,385 million, up 27%, and Operating EBIT of $1,278 million, driven by higher polyethylene prices despite lower volumes from planned maintenance. Industrial Intermediates & Infrastructure net sales increased 14% to $3,166 million and Operating EBIT improved to $246 million, supported by higher prices, lower maintenance and suspension of equity losses from Sadara. Performance Materials & Coatings grew sales 11% to $2,361 million with 6% higher volumes, though Operating EBIT declined to $133 million due to higher fixed costs and a siloxanes plant shutdown.
Cash provided by operating activities from continuing operations was $1,324 million, producing quarterly free cash flow of $692 million. The balance sheet showed total assets of $61,585 million and long-term debt of $17,151 million at June 30, 2026. Management expects approximately $200 million more 2026 benefits from Transform to Outperform, targeting greater than $1.3 billion of in-year self-help benefits and emphasizing ongoing efforts to build a leaner, more competitive, and resilient company.
Dow Inc. is registering 5,410,000 shares of its common stock under an existing Form S-3 shelf registration statement through a prospectus supplement dated July 10, 2026. These shares may be issued upon the exercise, settlement or vesting of certain awards granted under the Dow Inc. 2019 Stock Incentive Plan that are not eligible for registration on Form S-8. A legal opinion from the Corporate Secretary and Assistant General Counsel is filed as Exhibit 5.1 and incorporated into the registration statement.